Dexmedetomidine
Product Images NDC 17478-055

3 FDA label images from Akorn · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine (NDC 17478-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dex0d 0005 01

Dex0d 0005 01
Chemical structure of Dexmedetomidine hydrochloride showing the arrangement of atoms and bonds in the molecule.*
FDA Label Image

Dex0d 0005 02

Dex0d 0005 02
Dexmedetomidine HCl Injection 200 mcg/2 mL (100 mcg/mL) vial label by Akorn. The label indicates the drug must be diluted before intravenous use, for single-dose 2 mL vial, and to discard unused portion. It includes manufacturing location in Lake Forest, Illinois, and revision date of 12/16.*
FDA Label Image

Dex0d 0005 03

Dex0d 0005 03
Dexmedetomidine HCl Injection 200 mcg per 2 mL (100 mcg/mL) single-dose vials, preservative-free, sterile, for intravenous use only and labeled as must be diluted. Package contains 10 vials of 2 mL each. Manufactured by Akorn, with storage instructions and active/inactive ingredient details. Barcode and NDC 17478-055-02 are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.